Neurotech Startup Canaery Secures Over $4 Million in Seed Funding To Digitize the Sense of Smell
Canaery, the neurotech startup digitizing the sense of smell to enhance the way we perceive and monitor the world around us, announced today it has closed more than $4 million in seed funding to accelerate the development of its scent-sensing platform.
Oragenics Appoints Seasoned Vaccine Executive Kimberly Murphy as President and Chief Executive Officer
UF startup and UF Innovate | Sid Martin Biotech graduate Oragenics, a biotech company dedicated to fighting infectious diseases including coronaviruses, announces the appointment of Ms. Kimberly M. Murphy, member of the Board of Directors, as President and Chief Executive Officer effective June 23, 2022. Ms. Murphy brings more than 25 years of vaccine industry experience at leading pharmaceutical companies including serving as a key leader in the successful US and Global launch of Merck’s HPV/Gardasil Franchise. Ms. Murphy joined Oragenics’ Board of Directors in 2020.
Context Labs Announces Platform Partnerships To Accelerate Global Energy Transition
Context Labs, an enterprise data fabric climate technology company, announced a platform partnership with Encino Environmental Services, LLC and Satlantis, LLC, further building a technology ecosystem to measure emissions with high precision, bringing greater urgency and rigor to combatting climate change.
Florida Institute and MPWRM Resource Center Fund Amend Surgical
UF Innovate | Sid Martin Biotech alum Amend Surgical, Inc., an Alachua-based medical device company, announced that it has finalized a funding agreement with the Institute for Commercialization of Florida Technology (the Florida Institute) along with being awarded a substantial product development funding from The Michigan-Pittsburgh-Wyss Regenerative Medicine (MPWRM) Resource Center.
DHS Announces Cooling Solutions Prize Challenge Finalists in Celebration of Earth Day
UF startup Micro Nano Technologies, announced as finalists in the Cooling Solutions Challenge prize competition. Launched in September 2021, by DHS Science and Technology Directorate (S&T) and the Federal Emergency Management Agency (FEMA), this $195,000 prize competition marks the first in a series focusing on national climate resilience.
Entrinsic Bioscience Steps Closer to Amino Acid Formulation as Therapy for Cystic Fibrosis
Entrinsic Bioscience and its licensee Nuvara Therapeutics announce they are one step closer to using RxAA formulations as a therapy for patients with Cystic Fibrosis Class I mutations
Entrinsic Bioscience Announces Tool with Potential for Development of New Therapies Addressing Constipation
Entrinsic Bioscience announces a tool to measure intestinal peristalsis that could lead to the development of therapeutic agents for constipation, including Irritable Bowel Syndrome-Constipation (IBS-C).
Satlantis, LLC, Announces Strategic Investment
UF startup Satlantis, LLC (“Satlantis”), a US technology leader in high precision miniaturized satellites and cameras is pleased to announce a strategic investment from Encino Environmental Holdings, LLC (“Encino”). This investment will allow Satlantis to accelerate the commercialization of its satellite-based greenhouse gas (GHG) monitoring technology and develop new products and services for the North American market.
1000X More Efficient Neural Networks: Building an Artificial Brain With 86 Billion Physical (but Not Biological) Neurons
What if in our attempt to build artificial intelligence we don’t simulate neurons in code and mimic neural networks in Python, but instead build actual physical neurons connected by physical synapses in ways very similar to our own biological brains? That’s precisely what UF startup Rain Neuromorphics, is trying to do: build a non-biological yet very human-style artificial brain.
Lacerta Therapeutics Expands Executive Leadership Team
UF startup Lacerta Therapeutics, a preclinical-stage gene therapy company, announces an expansion in the executive leadership team: illustrating Lacerta’s commitment to developing a constellation of gene-based therapies.